amazon hims news - Search News

Amazon Gets Into Boner Pill Business, Hims Stock Goes Limp

MarketWatch on MSN · 21h

Hims & Hers’ stock tumbles on Amazon’s latest disruptive foray into healthcare

Hims & Hers Health Inc. shares tumbled 22% Thursday, on concerns that Amazon.com Inc.’s latest push into healthcare will disrupt Hims & Hers’ business. Amazon One Medical launched a new service Thursday that offers upfront pricing for telehealth visits for a range of issues and ailments — including men’s hair loss,

Amazon Gets Into the Boner Pill Business, Hims Stock Goes Limp

Amazon acquired primary care provider One Medical for $3.9 billion in 2022, and fills prescriptions through Amazon Pharmacy. Medications are packaged in standard Amazon packaging, so nobody will know you’re ordering boner pills.

Wall Street Journal · 20h

Hims & Hers Stock Drops After Amazon Says It Will Offer Hair-Loss Treatments

Shares of Hims & Hers slid after Amazon.com said it would offer cheap treatments for concerns like hair loss, skin care and erectile dysfunction, directly competing with the telehealth startup. Amazon on Thursday launched the treatments through its One Medical telehealth service,

Amazon, Hims

Seeking Alpha · 23h

Hims & Hers drops 22% on Amazon competition concerns (update)

Hims & Hers (HIMS) fell 22% after Amazon (AMZN) announced it was entering the hair loss and erectile dysfunction treatment markets through its telehealth unit. Read more here.

Fierce Healthcare · 1d

Amazon One Medical rolls out telehealth treatment services in competition with Ro, Hims & Hers

Amazon One Medical is rolling out a new service to provide Prime members access to clinical treatments for common health and lifestyle conditions like men's hair loss and anti-aging skin care. | Amazon One Medical is rolling out a new service to provide Prime members access to clinical treatments for common health and lifestyle conditions like men's hair loss and anti-aging skin care.

Business Insider · 17h

Hold Rating for Hims & Hers Health Amidst Competitive Pressure from Amazon’s Telehealth Services

Citi analyst Daniel Grosslight has maintained their neutral stance on HIMS stock, giving a Hold rating on November 6. Daniel

7hon MSN

Amazon launches fixed pricing for treatment of conditions such as hair loss. Hims & Hers stock drops 24%

Amazon announced Prime members can access new upfront pricing for treatment of five common conditions such as erectile ...

Yahoo Finance23h

Amazon launches lifestyle drug service as challenge to Hims & Hers

The move into lifestyle treatments is seen as a challenge to companies like Hims & Hers, which saw its stock value drop ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results